Dr. Nathalie Costedoat-Chalumeau

Nathalie Costedoat-Chalumeau MD, PhD, is currently Professor of Medicine at Paris V University and Senior Hospital practitioner at the Reference Center for Systemic and Autoimmune Diseases, Department of Medicine, Cochin Hospital and, one of the five French national reference in France for rare autoimmune and systemic diseases. She trained in Internal Medicine, Immunology, Pharmacology and Rheumatology at the Pitié-Salpêtrière and Cochin Hospitals in Paris; she joined the Cochin Hospital soon after completing her training, and in 2010 she became a Full Professor.

Natalie’s research and practice has focused on lupus and the antiphospholipid syndrome and has been involved on studies leading to landmark publications in hydroxychloroquine and its measurement in blood, adherence to treatment, and pregnancy in women with SLE and APS. She designed and successfully led several national and international longitudinal and cohort studies on SLE and APS: the PLUS study, the Adherence study, the GR2 study, and the neonatal lupus cohort (in collaboration with Dr. Jill Buyon, another SLICC member). She brings this extensive experience to the SLICC group.

Dr. Costedoat-Chalameau has published extensively including original papers in international journals; she is also a reviewer for national and international journal, and since 2013, member of the Editorial Board of Lupus Science and Medicine.

Categorised in:

This post was written by admin